Gala vs MangoRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MangoRx beats Gala overall, scoring 7.5/10 vs 7/10. Gala is more affordable at $149/mo vs $299/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose MangoRx for users who want a multi-service telehealth platform covering .
A side-by-side comparison of Gala and MangoRx covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaMangoRx
#24 of 42Multi-service telehealth platform offering compounded GLP-1 alongside other health services.
Visit MangoRx| Feature | Gala | MangoRx |
|---|---|---|
| Our Score | 7/10 | 7.5/10 |
| Starting Price | $149/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want a multi-service telehealth platform covering weight loss and men's health |
| Ranking | #40 | #24 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
MangoRx
Pros
- +Oral dissolving tablets exclusively — zero injections for any GLP-1 option
- +Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
- +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
- +Free 100% online consultation with no video call required
Cons
- −$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
- −Early-stage public company with limited revenue — stock performance reflects financial uncertainty
- −Only oral tablet format available — no injectable options if you want higher bioavailability
Our Verdict
MangoRx edges out Gala with a score of 7.5/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to MangoRx's $299/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health.